Arcus Biosciences, Inc.

RCUSNYSEHealthcare● Active

$23.41

+$0.22(+0.95%)

Market Cap$2.4B

P/E Ratio—

52W High$28.72

52W Low$7.91

Avg Volume1.2M

Open$23.67

Beta0.84

Employees Ownership Insider Trades

Arcus Biosciences, Inc. (RCUS) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · RCUS · as of Feb 25, 2026

Latest filing snapshot

601

-26-4.15%vs prior year

Arcus Biosciences, Inc. (RCUS) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

601

Change (1Y)

-26

Growth % (1Y)

-4.15%

Revenue / Employee

$411.0K

Net Income / Employee

$-587.4K

Market Cap

$2.3B

RCUS Employee Count

2018 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-02-25	2025-12-31	601	-26	-4.15%
2025-02-25	2024-12-31	627	+50	+8.67%
2024-02-21	2023-12-31	577	+77	+15.40%
2023-02-28	2022-12-31	500	+134	+36.61%
2022-02-23	2021-12-31	366	+130	+55.08%
2021-02-25	2020-12-31	236	+97	+69.78%
2020-03-05	2019-12-31	139	+31	+28.70%
2019-03-05	2018-12-31	108	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

Arcus Biosciences, Inc.YOU

601$2.3B #3

AGIO

Agios Pharmaceuticals, Inc.

486$1.6B #4

DNLI

Denali Therapeutics Inc.

443$3.1B #5

BEAM

Beam Therapeutics Inc.

393$3.0B #6

COGT

Cogent Biosciences, Inc.

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · RCUS peer comparison

About RCUS employees

RCUS Employees · Headcount

Arcus Biosciences, Inc. (RCUS) employee data is sourced from the annual SEC 10-K filing. As of 2025, Arcus Biosciences, Inc. had 601 full-time employees globally. Full-time employees only. Global consolidated headcount.

Arcus Biosciences, Inc. employs 601 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $410,982, reflecting the company's operational efficiency.

Arcus Biosciences, Inc.'s workforce decreased by 26 (4.15%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Arcus Biosciences, Inc.'s revenue per employee of $410,982 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

RCUS Employees · 5 questions

As of the latest SEC 10-K filing (2025), Arcus Biosciences, Inc. had 601 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Arcus Biosciences, Inc. employee counthow many employees does Arcus Biosciences, Inc. haveRCUS total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-25